I can confirm that, although it is also important to say that if we discover changes in procedures that will improve the safety of medicine use or medical device use, the people who put those new drugs on the market would want to benefit from any changes in regulatory processes, but what we would not want to do is reduce the speed.
Medicines and Medical Devices Safety Review
Proceeding contribution from
Jeremy Hunt
(Conservative)
in the House of Commons on Wednesday, 21 February 2018.
It occurred during Ministerial statement on Medicines and Medical Devices Safety Review.
Type
Proceeding contribution
Reference
636 c181 
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2020-07-09 15:43:21 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000041
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000041
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000041